Phase II study of weekly irinotecan (CPT-11) as second-line treatment of patients with advanced colorectal cancer

Author: Cassinello J.   López-Alvarez P.   Martínez-Guisado A.   Valladares M.   Huidobro G.   López R.   Bohn U.   Sevilla I.   Ballesteros P.   Jorge M.   Pérez-Carrión R.   Fernández J.   Dorta J.  

Publisher: Humana Press, Inc

ISSN: 1357-0560

Source: Medical Oncology, Vol.20, Iss.1, 2003-03, pp. : 37-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content